<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hypothesis-Based Particle Detection for Accurate Nanoparticle Counting and Digital Diagnostics - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel hypothesis-based particle counting algorithm designed for nanoparticle-based imaging assays, formulated as a multiple-hypothesis s">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Hypothesis-Based Particle Detection for Accurate Nanoparticle Counting and Digital Diagnostics</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.05346v1" target="_blank">2512.05346v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-05
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Neil H. Kim, Xiao-Liu Chu, Joseph B. DeGrandchamp, Matthew R. Foreman
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.comp-ph, physics.med-ph, physics.optics, q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.05346v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.05346v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel hypothesis-based particle counting algorithm designed for nanoparticle-based imaging assays, formulated as a multiple-hypothesis statistical test under an explicit image-formation model. The method achieves robust and interpretable nanoparticle counting without requiring training data or empirical parameter tuning, demonstrating its utility in detecting SARS-CoV-2 DNA biomarkers and providing insights into particle aggregation for digital molecular diagnostics.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This method is highly relevant for advancing digital diagnostics by enabling precise and reliable detection of low-abundance analytes, which is critical for early disease diagnosis, personalized medicine, and monitoring biomolecular reporters.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>While the paper's method is presented as an alternative to 'machine learning methods,' it addresses a core problem in medical diagnostics and image analysis‚Äîaccurate quantification of particles for biomarker detection. This is an area where medical AI/ML applications are actively developed for tasks like image interpretation, diagnosis, and prognostic prediction. By offering a model-based, interpretable framework for digital diagnostics, this research contributes to the broader field of computational methods for health, providing a valuable comparative perspective and alternative approach to AI-driven solutions in this domain. Thus, it operates within the application space where medical AI is highly relevant.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>A novel particle counting algorithm is presented, formulated as a multiple-hypothesis statistical test under an explicit image-formation model and evaluated via a penalized likelihood rule.</li>
                    
                    <li>The method distinguishes itself by requiring no training data or empirical parameter tuning, offering interpretable outputs directly linked to imaging physics and statistical decision theory.</li>
                    
                    <li>Numerical simulations confirm robust count accuracy across challenging conditions, including weak signals, variable backgrounds, magnification changes, and moderate Point Spread Function (PSF) mismatch.</li>
                    
                    <li>Particle resolvability tests characterized specific error modes: under-counting at very small particle separations and localized over-counting near the resolution limit.</li>
                    
                    <li>The algorithm was successfully applied to experimental dark-field images from a nanoparticle-based assay for SARS-CoV-2 DNA biomarkers.</li>
                    
                    <li>Statistically significant differences in particle count distributions were observed between control and positive SARS-CoV-2 samples, confirming diagnostic utility.</li>
                    
                    <li>Full count statistics exhibited consistent over-dispersion, providing valuable insights into non-specific and target-induced particle aggregation mechanisms.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The core methodology involves a particle counting algorithm structured as a multiple-hypothesis statistical test. It integrates an explicit image-formation model and utilizes a penalized likelihood rule for robust evaluation, fundamentally differing from traditional thresholding or machine learning approaches.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The algorithm demonstrated robust and accurate nanoparticle counting performance under varied and challenging imaging conditions. Experimentally, it successfully differentiated SARS-CoV-2 positive samples from controls with statistical significance and provided novel insights into particle aggregation dynamics through consistent over-dispersion in count statistics.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This framework offers a reliable, interpretable, and training-free solution for nanoparticle-based detection assays, directly enhancing the accuracy and robustness of digital molecular diagnostics. It has the potential to significantly improve early and precise detection of a wide range of disease biomarkers, including viral pathogens like SARS-CoV-2.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract notes that resolvability tests revealed characteristic error modes, specifically under-counting at very small particle separations and localized over-counting near the resolution limit, indicating challenges in accurately resolving extremely dense or closely spaced particles.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Infectious diseases</span>
                    
                    <span class="tag">Personalized medicine</span>
                    
                    <span class="tag">Early disease diagnosis</span>
                    
                    <span class="tag">Molecular diagnostics</span>
                    
                    <span class="tag">Medical imaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">nanoparticle counting</span>
                    
                    <span class="tag tag-keyword">digital diagnostics</span>
                    
                    <span class="tag tag-keyword">SARS-CoV-2</span>
                    
                    <span class="tag tag-keyword">multiple-hypothesis test</span>
                    
                    <span class="tag tag-keyword">image processing</span>
                    
                    <span class="tag tag-keyword">low-abundance analytes</span>
                    
                    <span class="tag tag-keyword">biomarker detection</span>
                    
                    <span class="tag tag-keyword">statistical decision theory</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Digital assays represent a shift from traditional diagnostics and enable the precise detection of low-abundance analytes, critical for early disease diagnosis and personalized medicine, through discrete counting of biomolecular reporters. Within this paradigm, we present a particle counting algorithm for nanoparticle based imaging assays, formulated as a multiple-hypothesis statistical test under an explicit image-formation model and evaluated using a penalized likelihood rule. In contrast to thresholding or machine learning methods, this approach requires no training data or empirical parameter tuning, and its outputs remain interpretable through direct links to imaging physics and statistical decision theory.
  Through numerical simulations we demonstrate robust count accuracy across weak signals, variable backgrounds, magnification changes and moderate PSF mismatch. Particle resolvability tests further reveal characteristic error modes, including under-counting at very small separations and localized over-counting near the resolution limit. Practically, we also confirm the algorithm's utility, through application to experimental dark-field images comprising a nanoparticle-based assay for detection of DNA biomarkers derived from SARS-CoV-2. Statistically significant differences in particle count distributions are observed between control and positive samples. Full count statistics obtained further exhibit consistent over-dispersion, and provide insight into non-specific and target-induced particle aggregation. These results establish our method as a reliable framework for nanoparticle-based detection assays in digital molecular diagnostics.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Main text (14 pages, 5 figures, 1 table) and supplementary information (5 pages, 3 figures, 2 tables). Supporting code at https://github.com/Optical-Theory-Group/Hypothesis-Test-Based-Particle-Detection</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>